← Back to Clinical Trials
Recruiting NCT06453291

NCT06453291 Assessment of Different Clinical Techniques to Treat Patients With Chronic Low Back Pain

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06453291
Status Recruiting
Phase
Sponsor Iffat Anwar Medical Complex
Condition Chronic Low Back Pain (CLBP)
Study Type INTERVENTIONAL
Enrollment 100 participants
Start Date 2024-07-10
Primary Completion 2025-04

Eligibility & Interventions

Sex All sexes
Min Age 40 Years
Max Age 60 Years
Study Type INTERVENTIONAL
Interventions
NSAIDs (Nonsteroidal Anti-Inflammatory Drugs):Standard Physical TherapyNeuromodulation via Dorsal Root Ganglion (DRG):

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 100 participants in total. It began in 2024-07-10 with a primary completion date of 2025-04.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This clinical trial aims to assess the effectiveness of different clinical techniques in treating patients with chronic low back pain (CLBP). Two test groups will be included: one receiving conventional therapy (NSAIDs and other physical therapy techniques) and the other receiving a combination of neuromodulation and platelet-rich plasma (PRP) therapy. Chronic pain, persisting for more than three months, inhibits natural pathways like GABA and promotes excitatory pathways, leading to increased inflammation. The study hypothesizes that neuromodulation via the dorsal root ganglion (DRG) and PRP therapy will provide superior pain relief and functional improvement compared to conventional therapy.

Eligibility Criteria

Inclusion Criteria: * Adults aged 40-60 years. * Diagnosed with chronic low back pain persisting for more than three months. * Willingness to participate and comply with study procedures. * Ability to provide informed consent. Exclusion Criteria: * Comorbidities. * Contagious and Non-Contagious Infections * Known hypersensitivity to study interventions. * Presence of severe psychiatric disorders. * Pregnancy or breastfeeding. * Participation in another clinical trial within the last 30 days.

Contact & Investigator

Central Contact

Shahzad Anwar, MBBS, DOM

✉ shahzadtirmzi@yahoo.com

📞 +923009400049

Principal Investigator

Shahzad Anwar, MBBS, DOM

PRINCIPAL INVESTIGATOR

Iffat Anwar Medical Complex, Lahore

Frequently Asked Questions

Who can join the NCT06453291 clinical trial?

This trial is open to participants of all sexes, aged 40 Years or older, up to 60 Years, studying Chronic Low Back Pain (CLBP). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06453291 currently recruiting?

Yes, NCT06453291 is actively recruiting participants. Contact the research team at shahzadtirmzi@yahoo.com for enrollment information.

Where is the NCT06453291 trial being conducted?

This trial is being conducted at Lahore, Pakistan.

Who is sponsoring the NCT06453291 clinical trial?

NCT06453291 is sponsored by Iffat Anwar Medical Complex. The principal investigator is Shahzad Anwar, MBBS, DOM at Iffat Anwar Medical Complex, Lahore. The trial plans to enroll 100 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology